Our catalog &amp; dosing protocols

Reference dosing: 50 mg typical dose · Once daily, oral

Small-molecule NNMT inhibitor under study for adipose-tissue methyl donor preservation, fat loss, and sarcopenia. Oral capsule.

Adipotide

Reference dosing: 1 mg typical dose · Cycled — provider supervised · 5 mg vial

aka FTPP

Pro-apoptotic targeted peptide that disrupts adipose vasculature. Preclinical only; nephrotoxicity observed at high doses.

RUO Not WADA-listed

AICAR

Reference dosing: 10 mg typical dose · Daily during cycle · 50 mg vial· titration ladder

aka Acadesine

AMPK activator studied for exercise mimetic and metabolic effects. WADA-prohibited as a metabolic modulator.

RUOWADA prohibited

AOD-9604

Reference dosing: 300 mcg typical dose · Daily · 5 mg vial· titration ladder

aka GH fragment 176-191

C-terminal fragment of human GH studied for lipolysis without affecting glucose or IGF-1. Did not meet endpoints in obesity trials.

MOTS-c

Reference dosing: 5 mg typical dose · 3× weekly · 10 mg vial· titration ladder

Mitochondrial-derived peptide implicated in metabolic homeostasis and insulin sensitivity. Preclinical/early human research only.

Tesofensine

4 in catalog

Triple monoamine reuptake inhibitor in Phase III for obesity (TIPO-4). Oral, once daily.

Testosterone/Anastrozole 200 is carried in the VitaRelay network as 503B outsourcing facility product in pellet form. Presentations and state-level availability vary by dispensing partner.

503B

Zomacton

Tretinoin/Niacinamide/Hyaluronic Acid 0.045%/4%/0.5%

Vitamin D3/Vitamin K2 10 is carried in the VitaRelay network as 503A compounded product in capsule/tablet form. Presentations and state-level availability vary by dispensing partner.

Healing & Recovery

ARA-290

Reference dosing: 4 mg typical dose · Daily × 28 days, cycled · 14 mg vial· titration ladder

aka Cibinetide

Erythropoietin-derived 11-mer that targets the innate repair receptor. Studied for neuropathic pain in sarcoidosis and diabetic neuropathy.

aka Body Protective Compound

BPC-157

31 in catalog

Pentadecapeptide derived from a gastric protein. Promoted for tendon/ligament repair and GI healing. No FDA approval; FDA placed on Category 2 compounding list.

Reference dosing: 250 mcg typical dose · 1–2× daily · 5 mg vial· titration ladder

Reference dosing: 2 mg typical dose · 2–3× weekly · 50 mg vial· titration ladder

GHK-Cu

9 in catalog

aka Copper Peptide

Copper-binding tripeptide implicated in wound healing, hair follicle stimulation, and skin remodeling. Used topically and via injection.

TB-500

aka Thymosin Beta-4 fragment

Synthetic fragment of thymosin β-4. Promoted for tissue repair and inflammation. WADA-prohibited in sport.

GLP-1 / Incretin

CagriSema

aka Cagrilintide + Semaglutide

Fixed-dose combination of amylin analog cagrilintide with semaglutide. Phase III REDEFINE program.

Reference dosing: 2.4 mg typical dose · Once weekly · 5 mg vial· titration ladder

Not WADA-listed

Retatrutide

Reference dosing: 12 mg typical dose · Once weekly · 10 mg vial· titration ladder

aka LY3437943

Triple GLP-1/GIP/glucagon receptor agonist. Phase III; ~24% weight loss reported in Phase II at 48 weeks.

503A Not WADA-listed

Semaglutide

43 in catalog

aka Ozempic, Wegovy, Rybelsus

GLP-1 receptor agonist for type 2 diabetes and chronic weight management. Standard 16-week titration to target dose.

Reference dosing: 2.4 mg typical dose · Once weekly · 5 mg vial· titration ladder

Survodutide

Reference dosing: 6 mg typical dose · Once weekly · 6 mg vial· titration ladder

aka BI 456906

Dual GLP-1/glucagon agonist. Phase III for obesity and MASH. ~52% liver-fat reduction reported in Phase II.

RUO Not WADA-listed

Tirzepatide

49 in catalog

aka Mounjaro, Zepbound

Dual GIP/GLP-1 receptor agonist. 5-dose escalation (2.5 → 15 mg) over 20+ weeks. Up to ~22% weight loss in SURMOUNT-1.

Cartalax

Cartalax is carried in the VitaRelay network as research & development product in lyophilized powder form. Presentations and state-level availability vary by dispensing partner.

REICover

REICover is carried in the VitaRelay network as research & development product in capsule/tablet form. Presentations and state-level availability vary by dispensing partner.

REICover Sample Pack

VIP is carried in the VitaRelay network as research & development product in lyophilized powder form. Presentations and state-level availability vary by dispensing partner.

Reference dosing: 100 mcg typical dose · 1–3× daily · 5 mg vial· titration ladder

GH Secretagogue

CJC-1295 (no DAC)

8 in catalog

aka Modified GRF 1-29

GHRH analog often stacked with ipamorelin to amplify endogenous GH pulses. WADA-prohibited.

GHRP-2

Reference dosing: 200 mcg typical dose · 1–3× daily · 5 mg vial· titration ladder

aka Pralmorelin

Synthetic hexapeptide ghrelin-receptor agonist. Stronger GH release than GHRP-6 with less appetite stimulation.

GHRP-6

Reference dosing: 200 mcg typical dose · 1–3× daily · 5 mg vial· titration ladder

Ghrelin-receptor agonist with marked appetite-stimulant effect. Often stacked with a GHRH (sermorelin or CJC-1295).

Hexarelin

Reference dosing: 100 mcg typical dose · 1–2× daily · 5 mg vial· titration ladder

Potent GH secretagogue with longer-lasting effect than GHRP-6; receptor desensitization can occur with chronic high doses.

RUOWADA prohibited

Ibutamoren

Reference dosing: 25 mg typical dose · Once daily, oral· titration ladder

aka MK-677

Oral non-peptide ghrelin agonist that elevates GH and IGF-1. Can raise fasting glucose and increase appetite.

503AWADA prohibited

IGF-1 LR3

Reference dosing: 40 mcg typical dose · Once daily · 1 mg vial· titration ladder

aka Long R3 IGF-1

Long-acting IGF-1 analog with extended half-life via reduced IGFBP binding. WADA-prohibited.

RUOWADA prohibited

Ipamorelin

Reference dosing: 300 mcg typical dose · 1–3× daily · 5 mg vial· titration ladder

Selective ghrelin/GHS-R agonist that triggers pulsatile GH release with minimal cortisol or prolactin impact. WADA-prohibited.

Sermorelin

aka GRF 1-29, Sermorelin Acetate

GHRH 1-29 analog that stimulates pulsatile endogenous GH release. Historically FDA-approved (Geref, withdrawn 2008); now compounded.

Reference dosing: 300 mcg typical dose · Nightly · 5 mg vial· titration ladder

Reference dosing: 2 mg typical dose · Nightly · 10 mg vial· titration ladder

Tesamorelin

19 in catalog

aka Egrifta

Stabilized GHRH analog FDA-approved for HIV-associated lipodystrophy. Often compounded with ipamorelin in anti-aging protocols.

aka Delta Sleep-Inducing Peptide

Longevity

DSIP

4 in catalog

Nonapeptide studied for sleep architecture, stress modulation, and pain. Limited modern human trial data.

Reference dosing: 200 mcg typical dose · Pre-sleep · 5 mg vial· titration ladder

Epithalon

Reference dosing: 10 mg typical dose · Daily × 10–20 days, cycled · 50 mg vial· titration ladder

aka Epitalon

Tetrapeptide studied in Russian gerontology for telomerase activation and pineal regulation. Human data limited to small studies.

Glutathione

Reference dosing: 200 mg typical dose · 1–3× weekly · 200 mg vial· titration ladder

aka GSH

Major endogenous antioxidant tripeptide. Compounded injectable and IV forms often paired with NAD+ protocols.

Humanin

Reference dosing: 250 mcg typical dose · Daily · 5 mg vial

Mitochondrial-derived peptide implicated in cytoprotection, insulin sensitivity, and neuronal survival. Early-stage research.

RUO Not WADA-listed

NAD+

10 in catalog

aka Nicotinamide Adenine Dinucleotide

Coenzyme central to redox metabolism and sirtuin signaling. Compounded injectable form used off-label for energy/longevity.

Reference dosing: 100 mg typical dose · 1–3× weekly · 500 mg vial· titration ladder

Rapamycin

aka Sirolimus

mTOR inhibitor FDA-approved as an immunosuppressant; off-label longevity dosing typically intermittent low-dose oral.

hCG

aka Human Chorionic Gonadotropin

LH-mimetic glycoprotein hormone used to preserve testicular function during TRT and for fertility support. Dosed in international units.

Reference dosing: 500–1500 IU, 2–3× weekly· titration ladder

Sexual Health

L-Arginine/Ergoloid Mesylate/Pentoxifylline/Sildenafil Citrate/Theophylline

L-Arginine/Ergoloid Mesylate/Pentoxifylline/Sildenafil Citrate/Theophylline is carried in the VitaRelay network as 503A compounded product in cream form. Presentations and state-level availability vary by dispensing partner.

Reference dosing: 30 mcg typical dose · PRN sublingual/nasal· titration ladder

Oxytocin

8 in catalog

Nonapeptide hormone with social-bonding and sexual-response effects. Compounded sublingual/nasal/troche forms used off-label.

aka Bremelanotide, Vyleesi

PT-141

4 in catalog

Vardenafil is carried in the VitaRelay network as 503A compounded product in capsule/tablet form. Presentations and state-level availability vary by dispensing partner.

Cognitive & Mood

Methylene Blue

5 in catalog

Thiazine dye with mitochondrial-electron-shuttle activity. Approved for methemoglobinemia; off-label low-dose oral use for cognition.

Nano Xsomes™ High-Potency Cord Blood–Derived Exosome Complex is carried in the VitaRelay network as research & development product in liquid form. Presentations and state-level availability vary by dispensing partner.